Shortened Multidrug-Resistant Tuberculosis Treatment in Settings with a High Prevalence of Ofloxacin Resistance
Journal
The European Respiratory JournalPublisher
European Respiratory SocietyPubMed ID
28729476Language
enDescription
We regret that this article is behind a paywall.ISSN
1399-3003ae974a485f413a2113503eed53cd6c53
10.1183/13993003.00598-2017
Scopus Count
Collections
Related articles
- Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
- Authors: Chang KC, Yew WW, Chan RC
- Issue date: 2010 Aug
- Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
- Authors: Jain A, Dixit P, Prasad R
- Issue date: 2012 Sep
- Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
- Authors: Chien JY, Chien ST, Chiu WY, Yu CJ, Hsueh PR
- Issue date: 2016 Aug
- Promising of Multidrug-resistant Tuberculosis Screening among New Tuberculosis Patients in China.
- Authors: Zhang H, Jia ZW
- Issue date: 2017 Sep 5
- Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
- Authors: Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM
- Issue date: 2012 Sep